Detalhe da pesquisa
1.
Positive experience of intraperitoneal chemotherapy followed by intravenous chemotherapy in heavily pretreated patients with suboptimal residual ovarian cancer and primary peritoneal cancer.
Tumori
; 96(6): 918-25, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21388052
2.
Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas.
Mol Cancer Ther
; 7(9): 2876-83, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18790768
3.
An update on targeted therapy in metastatic renal cell carcinoma.
Urol Oncol
; 30(3): 240-6, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-20456985
4.
Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis.
Cancer Chemother Pharmacol
; 69(3): 781-7, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22037881
5.
PET/CT imaging in gynecologic malignancies: a critical overview of its clinical impact and our retrospective single center analysis.
Crit Rev Oncol Hematol
; 83(1): 84-98, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22245509
6.
Bevacizumab and glioblastomas, a single-centre experience: how disease history and characteristics may affect clinical outcome.
Anticancer Res
; 30(12): 5213-6, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21187515
7.
Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688del.
Cancer Res
; 69(17): 7030-7, 2009 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19706752
8.
Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations.
Genes Chromosomes Cancer
; 45(9): 791-7, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16715518
9.
Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families.
Hum Mol Genet
; 12(9): 1055-61, 2003 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12700174